Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics

Molecular Therapy

Volumn 26, Issue 7, 2018, Pages 1635-1643

  Adamiak, Marta ^a   Sahoo, Susmita ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

exosomes; extracellular vesicles; heart repair; stem cells; therapeutics

Indexed keywords

NANOCARRIER;

BODY FLUID; CARDIAC STEM CELL; CELL ISOLATION; CELL LINEAGE; CELL REGENERATION; EXOSOME; HUMAN; IN VIVO STUDY; INTERSECTORAL COLLABORATION; MULTIPOTENT STEM CELL; MYOCARDIAL DISEASE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; ANIMAL; BIOLOGICAL THERAPY; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; HEART INFARCTION; METABOLISM; PROCEDURES; STEM CELL;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; EXOSOMES; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 85047402267     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1016/j.ymthe.2018.04.024     Document Type: Review

References (68)

1. World Health Organization. Cardiovascular disease. http://www.who.int/cardiovascular_diseases/en/, 2017.
2. Benjamin, E.J., Blaha, M.J., Chiuve, S.E., Cushman, M., Das, S.R., Deo, R., de Ferranti, S.D., Floyd, J., Fornage, M., Gillespie, C., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 135 (2017), e146–e603.
3. Taylor, D.A., Atkins, B.Z., Hungspreugs, P., Jones, T.R., Reedy, M.C., Hutcheson, K.A., Glower, D.D., Kraus, W.E., Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998), 929–933.
4. Cambria, E., Pasqualini, F.S., Wolint, P., Günter, J., Steiger, J., Bopp, A., Hoerstrup, S.P., Emmert, M.Y., Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. NPJ Regen. Med., 2, 2017, 17.
5. Tkach, M., Théry, C., Communication by extracellular vesicles: where we are and where we need to go. Cell 164 (2016), 1226–1232.
6. Shurtleff, M.J., Yao, J., Qin, Y., Nottingham, R.M., Temoche-Diaz, M.M., Schekman, R., Lambowitz, A.M., Broad role for YBX1 in defining the small noncoding RNA composition of exosomes. Proc. Natl. Acad. Sci. USA 114 (2017), E8987–E8995.
7. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
8. Maas, S.L.N., Breakefield, X.O., Weaver, A.M., Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 27 (2017), 172–188.
9. Théry, C., Zitvogel, L., Amigorena, S., Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2 (2002), 569–579.
10. Mulcahy, L.A., Pink, R.C., Carter, D.R., Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles, 3, 2014, 1.
11. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
12. Liang, Y., Sahoo, S., Exosomes explosion for cardiac resuscitation. J. Am. Coll. Cardiol. 66 (2015), 612–615.
13. Sahoo, S., Losordo, D.W., Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114 (2014), 333–344.
14. Adamiak, M., Cheng, G., Bobis-Wozowicz, S., Zhao, L., Kedracka-Krok, S., Samanta, A., Karnas, E., Xuan, Y.T., Skupien-Rabian, B., Chen, X., et al. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ. Res. 122 (2018), 296–309.
15. Khan, M., Nickoloff, E., Abramova, T., Johnson, J., Verma, S.K., Krishnamurthy, P., Mackie, A.R., Vaughan, E., Garikipati, V.N., Benedict, C., et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117 (2015), 52–64.
16. Wang, K., Jiang, Z., Webster, K.A., Chen, J., Hu, H., Zhou, Y., Zhao, J., Wang, L., Wang, Y., Zhong, Z., et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal microRNA-21. Stem Cells Transl. Med. 6 (2017), 209–222.
17. Ma, J., Zhao, Y., Sun, L., Sun, X., Zhao, X., Sun, X., Qian, H., Xu, W., Zhu, W., Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl. Med. 6 (2017), 51–59.
18. Zhu, J., Lu, K., Zhang, N., Zhao, Y., Ma, Q., Shen, J., Lin, Y., Xiang, P., Tang, Y., Hu, X., et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif. Cells Nanomed. Biotechnol., 2017, 10.1080/21691401.2017.1388249 Published online November 16, 2017.
19. Le, T., Chong, J., Cardiac progenitor cells for heart repair. Cell Death Discov., 2, 2016, 16052.
20. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M.V., Coletta, M., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95 (2004), 911–921.
21. Cheng, K., Malliaras, K., Smith, R.R., Shen, D., Sun, B., Blusztajn, A., Xie, Y., Ibrahim, A., Aminzadeh, M.A., Liu, W., et al. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Heart Fail. 2 (2014), 49–61.
22. Tseliou, E., Fouad, J., Reich, H., Slipczuk, L., de Couto, G., Aminzadeh, M., Middleton, R., Valle, J., Weixin, L., Marbán, E., Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles. J. Am. Coll. Cardiol. 66 (2015), 599–611.
23. Ibrahim, A.G., Cheng, K., Marbán, E., Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2 (2014), 606–619.
24. Gallet, R., Dawkins, J., Valle, J., Simsolo, E., de Couto, G., Middleton, R., Tseliou, E., Luthringer, D., Kreke, M., Smith, R.R., et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J. 38 (2017), 201–211.
25. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003), 763–776.
26. Bolli, R., Chugh, A.R., D'Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., Beache, G.M., Wagner, S.G., Leri, A., Hosoda, T., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378 (2011), 1847–1857.
27. Sultana, N., Zhang, L., Yan, J., Chen, J., Cai, W., Razzaque, S., Jeong, D., Sheng, W., Bu, L., Xu, M., et al. Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat. Commun., 6, 2015, 8701.
28. van Berlo, J.H., Kanisicak, O., Maillet, M., Vagnozzi, R.J., Karch, J., Lin, S.C., Middleton, R.C., Marbán, E., Molkentin, J.D., c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509 (2014), 337–341.
29. Sharma, S., Mishra, R., Bigham, G.E., Wehman, B., Khan, M.M., Xu, H., Saha, P., Goo, Y.A., Datla, S.R., Chen, L., et al. A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells. Circ. Res. 120 (2017), 816–834.
30. Agarwal, U., George, A., Bhutani, S., Ghosh-Choudhary, S., Maxwell, J.T., Brown, M.E., Mehta, Y., Platt, M.O., Liang, Y., Sahoo, S., Davis, M.E., Experimental, systems, and computational approaches to understanding the microRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circ. Res. 120 (2017), 701–712.
31. Sahoo, S., Klychko, E., Thorne, T., Misener, S., Schultz, K.M., Millay, M., Ito, A., Liu, T., Kamide, C., Agrawal, H., et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ. Res. 109 (2011), 724–728.
32. + stem cell exosomes in the repair of ischemic hindlimb. Circ. Res. 120 (2017), 1466–1476.
33. Vicencio, J.M., Yellon, D.M., Sivaraman, V., Das, D., Boi-Doku, C., Arjun, S., Zheng, Y., Riquelme, J.A., Kearney, J., Sharma, V., et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J. Am. Coll. Cardiol. 65 (2015), 1525–1536.
34. Beltrami, C., Besnier, M., Shantikumar, S., Shearn, A.I., Rajakaruna, C., Laftah, A., Sessa, F., Spinetti, G., Petretto, E., Angelini, G.D., Emanueli, C., Human pericardial fluid contains exosomes enriched with cardiovascular-expressed microRNAs and promotes therapeutic angiogenesis. Mol. Ther. 25 (2017), 679–693.
35. Sahoo, S., Mathiyalagan, P., Hajjar, R.J., Pericardial fluid exosomes: a new material to treat cardiovascular disease. Mol. Ther. 25 (2017), 568–569.
36. Ribeiro-Rodrigues, T.M., Laundos, T.L., Pereira-Carvalho, R., Batista-Almeida, D., Pereira, R., Coelho-Santos, V., Silva, A.P., Fernandes, R., Zuzarte, M., Enguita, F.J., et al. Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Cardiovasc. Res. 113 (2017), 1338–1350.
37. Marini, M., Ibba-Manneschi, L., Manetti, M., Cardiac telocyte-derived exosomes and their possible implications in cardiovascular pathophysiology. Adv. Exp. Med. Biol. 998 (2017), 237–254.
38. Bang, C., Batkai, S., Dangwal, S., Gupta, S.K., Foinquinos, A., Holzmann, A., Just, A., Remke, J., Zimmer, K., Zeug, A., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124 (2014), 2136–2146.
39. Hudry, E., Martin, C., Gandhi, S., György, B., Scheffer, D.I., Mu, D., Merkel, S.F., Mingozzi, F., Fitzpatrick, Z., Dimant, H., et al. Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther., 23, 2016, 819.
40. Liang, Y., Mathiyalagan, P., Kohlbrenner, E., Chepurko, E., Jeong, D., Ceholski, D., Dubois, N., Hajjar, R.J., Sahoo, S., Abstract 15439: AAV-containing exosomes as a novel vector to improve AAV-mediated myocardial gene delivery in resistance to neutralizing antibody. Circulation, 136(Suppl 1), 2017, A15439.
41. Dougherty, J.A., Mergaye, M., Kumar, N., Chen, C.A., Angelos, M.G., Khan, M., Potential role of exosomes in mending a broken heart: nanoshuttles propelling future clinical therapeutics forward. Stem Cells Int., 2017, 2017, 5785436.
42. Sluijter, J.P.G., Davidson, S.M., Boulanger, C.M., Buzás, E.I., de Kleijn, D.P.V., Engel, F.B., Giricz, Z., Hausenloy, D.J., Kishore, R., Lecour, S., et al. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc. Res. 114 (2018), 19–34.
43. Gimona, M., Pachler, K., Laner-Plamberger, S., Schallmoser, K., Rohde, E., Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int. J. Mol. Sci., 18, 2017, e1190.
44. Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F.A., Del Portillo, H.A., et al. Applying extracellular vesicles based therapeutics in clinical trials—an ISEV position paper. J. Extracell. Vesicles, 4, 2015, 30087.
45. Del Fattore, A., Luciano, R., Saracino, R., Battafarano, G., Rizzo, C., Pascucci, L., Alessandri, G., Pessina, A., Perrotta, A., Fierabracci, A., Muraca, M., Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. Expert Opin. Biol. Ther. 15 (2015), 495–504.
46. Willms, E., Johansson, H.J., Mäger, I., Lee, Y., Blomberg, K.E., Sadik, M., Alaarg, A., Smith, C.I., Lehtiö J., El Andaloussi, S., et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci. Rep., 6, 2016, 22519.
47. Collino, F., Pomatto, M., Bruno, S., Lindoso, R.S., Tapparo, M., Sicheng, W., Quesenberry, P., Camussi, G., Exosome and microvesicle-enriched fractions isolated from mesenchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells. Stem Cell Rev. 13 (2017), 226–243.
48. Lässer, C., Shelke, G.V., Yeri, A., Kim, D.K., Crescitelli, R., Raimondo, S., Sjöstrand, M., Gho, Y.S., Van Keuren Jensen, K., Lötvall, J., Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 14 (2017), 58–72.
49. Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J.P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., Théry, C., Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl. Acad. Sci. USA 113 (2016), E968–E977.
50. Brouwers, J.F., Aalberts, M., Jansen, J.W., van Niel, G., Wauben, M.H., Stout, T.A., Helms, J.B., Stoorvogel, W., Distinct lipid compositions of two types of human prostasomes. Proteomics 13 (2013), 1660–1666.
51. Lässer, C., Jang, S.C., Lötvall, J., Subpopulations of extracellular vesicles and their therapeutic potential. Mol. Aspects Med. 60 (2018), 1–14.
52. Ingato, D., Lee, J.U., Sim, S.J., Kwon, Y.J., Good things come in small packages: overcoming challenges to harness extracellular vesicles for therapeutic delivery. J. Control. Release 241 (2016), 174–185.
53. Wysoczynski, M., Ratajczak, M.Z., Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int. J. Cancer 125 (2009), 1595–1603.
54. Jeyaram, A., Jay, S.M., Preservation and storage stability of extracellular vesicles for therapeutic applications. AAPS J., 20, 2017, 1.
55. Kreke, M., Smith, R., Hanscome, P., Kiel, P., Ibrahim, A., Processes for producing stable exosome formulations. US patent application publication US 2016/0158291 A1, 2016 filed December 3, 2015, and published June 9, 2016.
56. Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., Martinez, Z.A., Baetens, T., Beghein, E., Bertier, L., et al., EV-TRACK Consortium. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14 (2017), 228–232.
57. Witwer, K.W., Buzás, E.I., Bemis, L.T., Bora, A., Lässer, C., Lötvall, J., Nolte-’t Hoen, E.N., Piper, M.G., Sivaraman, S., Skog, J., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles, 2, 2013, 1.
58. Lötvall, J., Hill, A.F., Hochberg, F., Buzás, E.I., Di Vizio, D., Gardiner, C., Gho, Y.S., Kurochkin, I.V., Mathivanan, S., Quesenberry, P., et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles, 3, 2014, 26913.
59. Mateescu, B., Kowal, E.J., van Balkom, B.W., Bartel, S., Bhattacharyya, S.N., Buzás, E.I., Buck, A.H., de Candia, P., Chow, F.W., Das, S., et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA—an ISEV position paper. J. Extracell. Vesicles, 6, 2017, 1286095.
60. Hill, A.F., Pegtel, D.M., Lambertz, U., Leonardi, T., O'Driscoll, L., Pluchino, S., Ter-Ovanesyan, D., Nolte-’t Hoen, E.N., ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J. Extracell. Vesicles, 2, 2013, 1.
61. Erdbrügger, U., Lannigan, J., Analytical challenges of extracellular vesicle detection: a comparison of different techniques. Cytometry A 89 (2016), 123–134.
62. Gangadaran, P., Hong, C.M., Ahn, B.C., Current perspectives on in vivo noninvasive tracking of extracellular vesicles with molecular imaging. BioMed Res. Int., 2017, 2017, 9158319.
63. Varga, Z., Gyurkó I., Pálóczi, K., Buzás, E.I., Horváth, I., Hegedűs, N., Máthé D., Szigeti, K., Radiolabeling of extracellular vesicles with (99m)Tc for quantitative in vivo imaging studies. Cancer Biother. Radiopharm. 31 (2016), 168–173.
64. Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M.W., Anchordoquy, T.J., Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J. Control. Release 199 (2015), 145–155.
65. Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., Zhang, X., Qin, G., He, S.H., Zimmerman, A., et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int. J. Cardiol. 192 (2015), 61–69.
66. Mocharla, P., Briand, S., Giannotti, G., Dörries, C., Jakob, P., Paneni, F., Lüscher, T., Landmesser, U., AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 121 (2013), 226–236.
67. Mackie, A.R., Klyachko, E., Thorne, T., Schultz, K.M., Millay, M., Ito, A., Kamide, C.E., Liu, T., Gupta, R., Sahoo, S., et al. Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ. Res. 111 (2012), 312–321.
68. Foglio, E., Puddighinu, G., Fasanaro, P., D'Arcangelo, D., Perrone, G.A., Mocini, D., Campanella, C., Coppola, L., Logozzi, M., Azzarito, T., et al. Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis. Int. J. Cardiol. 197 (2015), 333–347.